SPGI vs CME vs ICE
161 measures in 16 categories, one definition each, computed from filings and market data.
SPGI74.4
S&P Global Inc.
Financial Services · Financial - Data & Stock Exchanges
$429.64 +1.14%$126.7B mkt cap
Score DNA
CME56.5
CME Group Inc.
Financial Services · Financial - Data & Stock Exchanges
$293.87 +1.52%$105.7B mkt cap
Score DNA
ICE58.6
Intercontinental Exchange, Inc.
Financial Services · Financial - Data & Stock Exchanges
$161.56 +1.99%$90.7B mkt cap
Score DNA
Price, rebased to 100 three years ago
SPGI CME ICE · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | SPGI | CME | ICE |
|---|---|---|---|
| Insider open-market buys, 180d | 3 | 3 | 0 |
| Insider $ bought, 180d | $2.58M | $0.16M | — |
| Congress purchases, 180d | 18 | 0 | 3 |
| Last Congress purchase | 2026-08-27 | — | 2026-07-07 |
| 13F net change in holders | −97 | −90 | −57 |
| ETFs adding shares, 30d | 1,346 | 1,338 | 1,303 |
| ETFs trimming, 30d | 1,175 | 1,135 | 1,144 |
| Net ETF funds, 30d | +171 | +203 | +159 |
Valuation
16 measures| Measure | SPGI | CME | ICE |
|---|---|---|---|
| P/E (TTM) | 25.7x
67th
|
24.7x
56th
|
22.5x
44th
|
| PEG (P/E ÷ 3-yr EPS CAGR) | 0.82
33rd
|
1.98
78th
|
0.68
22nd
|
| Price / sales | 7.9x
50th
|
15.6x
100th
|
7.3x
40th
|
| Price / book | 4.0x
56th
|
4.0x
44th
|
3.1x
11th
|
| Price / tangible book | — | — | — |
| Price / free cash flow | 22.7x
50th
|
25.1x
80th
|
18.7x
40th
|
| Price / operating cash flow | 22.1x
50th
|
24.5x
80th
|
16.4x
30th
|
| Enterprise value | $138.3B
100th
|
$106.8B
80th
|
$109.3B
90th
|
| EV / sales | 8.6x
50th
|
15.8x
100th
|
8.8x
60th
|
| EV / EBITDA | 16.8x
44th
|
19.5x
67th
|
16.3x
33rd
|
| EV / EBIT | 19.7x
33rd
|
20.5x
44th
|
21.2x
56th
|
| EV / free cash flow | 24.8x
60th
|
25.4x
70th
|
22.5x
40th
|
| Earnings yield | 3.9%
40th
|
4.0%
50th
|
4.4%
60th
|
| FCF yield | 4.4%
50th
|
4.0%
20th
|
5.3%
60th
|
| Operating cash flow yield | 4.5%
50th
|
4.1%
20th
|
6.1%
70th
|
| Graham number (per share) | $200.24
100th
|
$139.38
88th
|
$91.42
62nd
|
Profitability (TTM)
12 measures| Measure | SPGI | CME | ICE |
|---|---|---|---|
| Gross margin | 70.9%
50th
|
81.9%
90th
|
79.0%
80th
|
| EBITDA margin | 51.0%
70th
|
80.9%
100th
|
53.7%
80th
|
| Operating margin | 46.3%
80th
|
65.1%
100th
|
43.5%
60th
|
| EBIT margin | 43.6%
80th
|
76.8%
100th
|
41.3%
60th
|
| Net margin | 30.5%
50th
|
63.1%
100th
|
32.3%
60th
|
| NOPAT margin | 35.8%
80th
|
49.7%
100th
|
33.4%
60th
|
| FCF margin | 34.6%
40th
|
62.2%
100th
|
38.8%
50th
|
| Operating cash flow margin | 35.5%
40th
|
63.6%
100th
|
44.2%
60th
|
| R&D / revenue | 0.0%
0th
|
0.0%
0th
|
0.0%
0th
|
| SG&A / revenue | 16.9%
30th
|
2.1%
0th
|
25.6%
70th
|
| Stock comp / revenue | 1.1%
10th
|
1.5%
20th
|
2.1%
40th
|
| Effective tax rate | 22.6%
60th
|
23.6%
80th
|
23.4%
70th
|
Returns on capital
11 measures| Measure | SPGI | CME | ICE |
|---|---|---|---|
| ROE (on average equity) | 15.1%
22nd
|
15.7%
33rd
|
13.9%
11th
|
| ROA | 8.0%
50th
|
2.3%
10th
|
2.5%
20th
|
| ROIC | 13.4%
60th
|
12.2%
50th
|
8.7%
10th
|
| ROCE | 13.1%
50th
|
14.5%
60th
|
9.6%
20th
|
| Return on tangible assets | 11.4%
60th
|
2.8%
20th
|
3.2%
30th
|
| Cash ROIC (OCF / invested capital) | 13.3%
30th
|
15.6%
40th
|
11.5%
10th
|
| Gross profitability (GP / assets) | 18.2%
40th
|
2.8%
0th
|
5.7%
10th
|
| ROIC, 3-yr average | 9.4%
30th
|
10.3%
40th
|
6.0%
10th
|
| ROIC, 5-yr average | 9.6%
22nd
|
11.4%
44th
|
7.0%
0th
|
| ROE, 5-yr average | 10.6%
11th
|
12.6%
44th
|
10.9%
22nd
|
| Incremental ROIC | 135.6%
90th
|
-41.1%
50th
|
94.7%
80th
|
Growth
17 measures| Measure | SPGI | CME | ICE |
|---|---|---|---|
| Revenue growth (TTM YoY) | 9.7%
70th
|
5.1%
30th
|
-0.6%
20th
|
| Revenue growth (QoQ) | -0.6%
30th
|
-9.2%
20th
|
-27.3%
0th
|
| Revenue CAGR, 3 yr | 10.2%
60th
|
8.9%
20th
|
9.2%
30th
|
| Revenue CAGR, 5 yr | 15.5%
90th
|
8.0%
40th
|
7.4%
20th
|
| Gross profit CAGR, 3 yr | 12.9%
50th
|
7.7%
30th
|
23.1%
80th
|
| Operating income CAGR, 3 yr | 27.2%
89th
|
11.7%
22nd
|
13.7%
44th
|
| Net income growth (TTM YoY) | 22.7%
56th
|
13.7%
33rd
|
34.1%
89th
|
| Net income CAGR, 3 yr | 28.0%
67th
|
12.8%
22nd
|
33.6%
78th
|
| EPS growth (TTM YoY) | 27.1%
56th
|
13.1%
22nd
|
36.2%
89th
|
| EPS CAGR, 3 yr | 31.4%
67th
|
12.5%
22nd
|
33.2%
78th
|
| EPS CAGR, 5 yr | 10.3%
56th
|
17.1%
89th
|
7.4%
22nd
|
| FCF growth (TTM YoY) | 3.0%
30th
|
2.6%
20th
|
10.8%
50th
|
| FCF CAGR, 3 yr | 20.5%
70th
|
10.7%
40th
|
15.4%
60th
|
| Operating cash flow CAGR, 3 yr | 20.3%
90th
|
10.5%
40th
|
14.9%
60th
|
| Book value CAGR, 3 yr | -1.3%
22nd
|
-1.8%
11th
|
7.1%
56th
|
| Dividend CAGR, 3 yr | 2.8%
62nd
|
1.6%
12th
|
1.7%
25th
|
| Sustainable growth rate | 11.6%
50th
|
0.7%
0th
|
10.0%
25th
|
Margin history & stability
7 measures| Measure | SPGI | CME | ICE |
|---|---|---|---|
| Gross margin, 3-yr average | 69.6%
70th
|
84.7%
100th
|
63.7%
50th
|
| Operating margin, 3-yr average | 40.8%
70th
|
64.4%
100th
|
39.0%
60th
|
| Net margin, 3-yr average | 27.6%
60th
|
59.4%
100th
|
25.9%
50th
|
| FCF margin, 3-yr average | 35.6%
70th
|
62.1%
100th
|
34.9%
50th
|
| Revenue stability (0-1) | 0.99
70th
|
0.98
60th
|
0.91
30th
|
| Earnings stability (0-1) | 0.61
70th
|
0.94
90th
|
0.13
20th
|
| Margin stability (0-1) | 0.96
60th
|
0.97
90th
|
0.82
10th
|
Liquidity (latest quarter)
7 measures| Measure | SPGI | CME | ICE |
|---|---|---|---|
| Cash & short-term investments | $4.1B
90th
|
$2.3B
70th
|
$2.0B
60th
|
| Net cash (− = net debt) | −$11.6B
10th
|
−$1.1B
80th
|
−$18.6B
0th
|
| Working capital | −$416.0M
20th
|
$2.8B
90th
|
$1.5B
80th
|
| Current ratio | 0.95
30th
|
1.02
50th
|
1.01
40th
|
| Quick ratio | 0.95
40th
|
1.02
50th
|
0.04
0th
|
| Cash ratio (cash + ST investments / current liabilities) | 0.45
50th
|
0.01
0th
|
0.02
10th
|
| Defensive interval (days) | 697 days
70th
|
972 days
90th
|
315 days
0th
|
Leverage & solvency (latest quarter)
13 measures| Measure | SPGI | CME | ICE |
|---|---|---|---|
| Total debt | $15.7B
90th
|
$3.4B
30th
|
$20.5B
100th
|
| Debt / equity | 0.50
22nd
|
0.13
11th
|
0.69
44th
|
| Net debt / equity | 0.37
33rd
|
0.04
22nd
|
0.63
56th
|
| Debt / assets | 25.0%
30th
|
1.8%
10th
|
11.8%
20th
|
| Debt / capital | 33.2%
22nd
|
11.4%
11th
|
41.0%
44th
|
| Debt / EBITDA | 1.91
44th
|
0.63
11th
|
3.07
78th
|
| Net debt / EBITDA | 1.41
33rd
|
0.21
11th
|
2.77
89th
|
| Interest coverage (EBIT / interest) | 22.2x
89th
|
59.3x
100th
|
6.6x
22nd
|
| Cash interest coverage | 18.1x
78th
|
49.1x
100th
|
7.1x
22nd
|
| Debt payback (years of OCF) | 2.7 yrs
50th
|
0.8 yrs
10th
|
3.7 yrs
70th
|
| Liabilities / assets | 41.8%
10th
|
86.4%
90th
|
83.0%
80th
|
| IS credit model rating | AA- | A+ | A |
| Implied credit spread (bps) | 100
10th
|
125
20th
|
150
50th
|
Efficiency
11 measures| Measure | SPGI | CME | ICE |
|---|---|---|---|
| Asset turnover | 0.26
40th
|
0.04
0th
|
0.08
10th
|
| Fixed asset turnover | 24.96
100th
|
19.28
90th
|
4.33
0th
|
| Inventory turnover | — | — | 0.0 |
| Receivables turnover | 5.0
30th
|
9.5
80th
|
7.1
50th
|
| Days sales outstanding | 73 days
70th
|
38 days
20th
|
51 days
50th
|
| Days inventory outstanding | — | — | — |
| Days payables outstanding | 44 days
70th
|
24 days
30th
|
155 days
100th
|
| Cash conversion cycle (days) | 28 days
89th
|
14 days
56th
|
— |
| Capex / revenue | 1.0%
33rd
|
1.4%
44th
|
5.3%
78th
|
| Capex / depreciation | 0.13
22nd
|
0.35
44th
|
0.43
56th
|
| Operating expense ratio | 21.1%
10th
|
4.4%
0th
|
47.8%
90th
|
Cash flow & earnings quality
7 measures| Measure | SPGI | CME | ICE |
|---|---|---|---|
| Operating cash flow / net income | 1.16
33rd
|
1.01
11th
|
1.37
78th
|
| FCF / net income | 1.13
44th
|
0.99
22nd
|
1.20
78th
|
| FCF / operating cash flow | 97.3%
56th
|
97.8%
67th
|
87.9%
44th
|
| Capex / operating cash flow | 2.7%
44th
|
2.2%
33rd
|
12.1%
56th
|
| Accruals ratio | -1.3%
60th
|
-0.0%
90th
|
-0.9%
80th
|
| Sloan accruals ratio | -2.5%
70th
|
-0.0%
90th
|
-0.4%
80th
|
| Earnings quality score (0-1) | 1.00
33rd
|
1.00
33rd
|
1.00
33rd
|
Scores & forensic checks
15 measures| Measure | SPGI | CME | ICE |
|---|---|---|---|
| IS score | 74
90th
|
56
10th
|
59
20th
|
| IS profitability | 80
90th
|
75
50th
|
74
20th
|
| IS growth | 63
70th
|
53
40th
|
56
50th
|
| IS value | 52
40th
|
56
60th
|
58
80th
|
| IS momentum | 87
80th
|
74
30th
|
85
60th
|
| IS risk (safety) | 100
10th
|
65
0th
|
100
10th
|
| IS quality | 84
90th
|
80
70th
|
85
100th
|
| IS balance sheet | 62
90th
|
60
80th
|
42
10th
|
| IS earnings quality | 74
40th
|
82
80th
|
83
90th
|
| IS cash flow | 75
30th
|
83
90th
|
78
70th
|
| Piotroski F-score (0-9) | 7
50th
|
6
30th
|
8
80th
|
| Altman Z-score | — | — | — |
| Beneish M-score | — | — | — |
| Ohlson O-score | −9.47
0th
|
−6.77
80th
|
−6.99
70th
|
| IS credit score | 80
90th
|
80
80th
|
74
50th
|
Size (TTM)
8 measures| Measure | SPGI | CME | ICE |
|---|---|---|---|
| Market cap | $126.7B
100th
|
$105.7B
90th
|
$90.7B
80th
|
| Revenue | $16.1B
100th
|
$6.8B
60th
|
$12.5B
90th
|
| EBITDA | $8.2B
100th
|
$5.5B
80th
|
$6.7B
90th
|
| Net income | $4.9B
100th
|
$4.3B
90th
|
$4.0B
80th
|
| Free cash flow | $5.6B
100th
|
$4.2B
80th
|
$4.8B
90th
|
| Total assets | $62.9B
80th
|
$194.7B
100th
|
$174.2B
90th
|
| Shareholders' equity | $31.6B
100th
|
$26.5B
80th
|
$29.6B
90th
|
| Employees | 44,500
100th
|
3,875
10th
|
12,725
70th
|
Price performance
9 measures| Measure | SPGI | CME | ICE |
|---|---|---|---|
| 1 day | +1.1% | +1.5% | +2.0% |
| 1 week | +5.3% | +4.7% | +3.4% |
| 1 month | +6.3% | +8.4% | +5.4% |
| 3 months | −4.2% | +19.9% | +14.1% |
| 6 months | −2.9% | +2.2% | +0.2% |
| Year to date | −16.0% | +9.0% | +1.0% |
| 1 year | −10.8% | +10.1% | +2.9% |
| 3 years, cumulative | +17.5% | +48.8% | +49.0% |
| 5 years, cumulative | +3.6% | +74.0% | +33.3% |
Technicals
4 measures| Measure | SPGI | CME | ICE |
|---|---|---|---|
| RSI 14 | 65.4 | 71.4 | 64.0 |
| From 52-week high | −22.0% | −8.6% | −8.2% |
| From 52-week low | +15.6% | +34.6% | +32.7% |
| Beta | 1.09 | 0.27 | 0.94 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17